Jiani Xie

ORCID: 0000-0003-0724-7041
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ginseng Biological Effects and Applications
  • Endometriosis Research and Treatment
  • Endometrial and Cervical Cancer Treatments
  • Protein Tyrosine Phosphatases
  • Ovarian cancer diagnosis and treatment
  • Bone Metabolism and Diseases
  • Ovarian function and disorders
  • Phytochemistry and Bioactive Compounds
  • Lipid metabolism and disorders
  • Cancer, Lipids, and Metabolism
  • Cancer-related molecular mechanisms research
  • Medicinal Plant Pharmacodynamics Research
  • Traditional Chinese Medicine Analysis

Shanghai University of Traditional Chinese Medicine
2022-2024

Shanghai Traditional Chinese Medicine Hospital
2021-2024

Creative Commons
2021

National Natural Science Foundation of China
2021

Weatherford College
2021

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. Cryptotanshinone (CRY) has been shown to be effective reversing reproductive disorders, but whether it can used treatment polycystic remains unclear. We aimed explore mechanism cryptotanshinone driven via regulating ferroptosis. A rat model PCOS was established by daily injection human chorionic gonadotropin and insulin for 22 days. An vitro ischemia-reperfusion (IR) granulosa cells...

10.1155/2022/8011850 article EN cc-by Oxidative Medicine and Cellular Longevity 2022-04-04

Polycystic ovary syndrome (PCOS) is a common disease affecting women of reproductive age; there need for interventions to address this condition. Herein, the network pharmacology approach was used explore potential combining Morindae Officinalis Radix (Bajitian) and Salviae (Danshen) treating PCOS. The bioactive ingredients Bajitian-Danshen pair were identified predicting therapeutic target genes. Genes related PCOS predicted by keyword search from various databases intersected with targets...

10.1016/j.arabjc.2024.105641 article EN cc-by-nc-nd Arabian Journal of Chemistry 2024-02-03

Polycystic ovary syndrome (PCOS) constitutes an endocrine and metabolic disorder characterized by hyperandrogenemia, ovulation disorders, polycystic ovary. Existing therapy is low efficacy has significant side effects. In traditional Chinese medicine, tanshinone was used for PCOS women. Here, we will investigate the safety, as well of in treating syndrome.Two researchers independently research eligible randomized controlled trials 6 repositories: PubMed, CINAHL, Web Science, EMBASE, China...

10.1097/md.0000000000024287 article EN cc-by-nc Medicine 2021-01-22
Coming Soon ...